Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Asmaa A. Ashour"'
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 3270-3280 (2022)
Liver fibrosis is a global life-threatening disorder with no approved treatment. It leads to serious hepatic complications when progressive, such as cirrhosis and carcinoma. Luteolin (LUT) is a plant flavonoid possessing a promising therapeutic poten
Externí odkaz:
https://doaj.org/article/e3373b5b44d643358a3ea6610bb2c653
Autor:
Alaa R. Aboushanab, Riham M. El-Moslemany, Amal H. El-Kamel, Radwa A. Mehanna, Basant A. Bakr, Asmaa A. Ashour
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1480 (2023)
Fisetin (FS) is considered a safer phytomedicine alternative to conventional chemotherapeutics for breast cancer treatment. Despite its surpassing therapeutic potential, its clinical utility is hampered by its low systemic bioavailability. Accordingl
Externí odkaz:
https://doaj.org/article/8ea141b0fb5f4ef790e9a8baa30ef2d1
Publikováno v:
Al-Azhar Dental Journal for Girls. 8:577-582
Publikováno v:
International Journal of Nanomedicine
Introduction Liver fibrosis represents a serious global disease with no approved treatment. Tanshinone IIA (TSIIA) is a phytomedicine with documented activity in treating many hepatic disorders. TSIIA has been reported to have potent anti-inflammator
Autor:
Riham M, El-Moslemany, Amal H, El-Kamel, Eman A, Allam, Hoda M, Khalifa, Ahmed, Hussein, Asmaa A, Ashour
Publikováno v:
Biomedicine & Pharmacotherapy. 155:113666
Acute lung injury (ALI) and its more serious form; acute respiratory distress syndrome are major causes of COVID-19 related mortality. Finding new therapeutic targets for ALI is thus of great interest. This work aimed to prepare a biocompatible nanof
Publikováno v:
International Journal of Pharmaceutics. 586:119598
Tanshinone IIA (TSIIA) is a promising phytomedicine that has been extensively studied due to its numerous biological activities, especially as an anticancer drug. However, it suffers from poor oral bioavailability owing to low aqueous solubility, poo
Publikováno v:
International Journal of Nanomedicine
Asmaa A Ashour,1 Dina Raafat,2 Hanan M El-Gowelli,3 Amal H El-Kamel1 1Department of Pharmaceutics, 2Department of Pharmaceutical Microbiology, 3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt B